ClinVar Miner

Submissions for variant NM_001999.4(FBN2):c.5031C>T (p.Cys1677=)

gnomAD frequency: 0.00035  dbSNP: rs147452231
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000633623 SCV000716678 likely benign not provided 2021-01-05 criteria provided, single submitter clinical testing
Ambry Genetics RCV002315903 SCV000739001 likely benign Familial thoracic aortic aneurysm and aortic dissection 2017-02-01 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000633623 SCV001157328 likely benign not provided 2019-11-21 criteria provided, single submitter clinical testing
Invitae RCV002063018 SCV002489230 likely benign Congenital contractural arachnodactyly 2021-07-15 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000633623 SCV004159323 likely benign not provided 2023-06-01 criteria provided, single submitter clinical testing FBN2: BP4, BP7

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.